Star Wars Box Office Haul Exceeds Projections but Lands on Low End of DisneyEra Openings Stock Market Today Indices Show Mixed Performance Amid Earnings Season Focus SEBI Chief Tuhin Kanta Pandey Highlights Indias Diversified Market Amid Taiwans Ascent on TSMC and AI Boom Intuits Latest Earnings Results Test Morgan Stanleys Stock Projection Trump Seeks Supreme Court Intervention to Halt Imminent TikTok Ban Workday Rises on Margin Forecast Boost Amid AI Momentum CGBD Q1 2026 Earnings Narrow EPS Miss Amid Stable Credit Performance Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4 Runway Growth Finance Corp RWAY Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady Six Flags Entertainment Q1 2026 Earnings Narrowerthanexpected loss amid seasonal headwinds FCPT Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds KRNY Q1 2026 Earnings EPS Misses Estimates Amid Cautious Quarter AvePoint AVPT Edges Higher Amid Steady Trading Key Support and Resistance Levels in Focus POMDOCTOR Limited POM Shares Slide 11 as Stock Nears Critical 010 Floor American International Group AIG Shows Modest Gains as Stock Hovers Between Key Levels Core Scientific Warrants CORZW Surge Over 5 Key Levels to Watch Alliance Entertainment Holding Corporation Warrant AENTW Gains 463 Approaches Key Resistance at 053 Mark Cuban Warns Healthcare Conglomerates Abuse Power Calls for Antitrust Enforcement NAGE Q1 2026 Earnings EPS Beats Estimates by a Slim Margin Stock Declines Mueller Water Products MWA Holds Steady Near Resistance as Small Gains Persist NACCO Industries NC Q1 2026 Earnings EPS of 117 Reported Amid Limited Disclosure REVB Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Challenges HDB Q1 FY2026 Earnings EPS Surpasses Estimates by 073 ODD Q4 2025 Earnings Earnings Beat on Strong EPS Surprise AUTL Q1 2026 Earnings Biotech Posts WiderThanExpected Loss as Stock Edges Higher Energous Corporation WATT Q1 2026 Earnings EPS Surprises to the Upside Amid Zero Revenue Quarter SGMO Q1 2026 Earnings Gene Therapy Focus Drives Stock Higher Despite Deep EPS Miss